According to the IARC database (2018), 42.51% of head and neck cancers carry somatic mutations in TP53. Studies have reported single nucleotide polymorphism (SNP) at the TP53 exon 4 codon 72, as a risk factor for development of cancer including OSCC (Sand et al., 2012). This evidence concerns the gene TP53 and cancer.